Last updated on Oct 22, 2020. Gilead gets Japanese approval for remdesivir – a.k.a. We comply with the HONcode standard for trustworthy health information -, FDA: Remdesivir (Veklury) Approval for the Treatment of COVID-19 - The Evidence for Safety and Efficacy, Baricitinib and Remdesivir Combination Receives Emergency Use Authorization from the FDA for the Treatment of Hospitalized Patients with COVID-19, An Open Letter from Merdad Parsey, Chief Medical Officer, Gilead Sciences, Gilead Sciences Statement on the Solidarity Trial, NIH Clinical Trial Testing Hyperimmune Intravenous Immunoglobulin Plus Remdesivir to Treat COVID-19 Begins, Final Results of National Institute of Allergy and Infectious Diseases’ ACTT-1 Trial Published in New England Journal of Medicine Expand Clinical Benefits of Veklury® (remdesivir) for the Treatment of COVID-19, Gilead Sciences Update on Supply and Distribution of Veklury (remdesivir) in the United States, Gilead’s Investigational Antiviral Veklury (Remdesivir) Receives U.S. Food and Drug Administration Emergency Use Authorization for the Treatment of Patients With Moderate COVID-19, Gilead Submits New Drug Application to U.S. Food and Drug Administration for Veklury (remdesivir) for the Treatment of COVID-19, Gilead Sciences Update on Veklury® (Remdesivir) Manufacturing Network, Gilead Sciences Statement on State Attorneys General Letter on Remdesivir, Gilead Presents Additional Data on Investigational Antiviral Remdesivir for the Treatment of COVID-19, Gilead Sciences Statement on the Initiation of Clinical Testing of an Inhaled Solution of Remdesivir for Potential Outpatient Treatment of COVID-19, Gilead Sciences Statement on Phase 2/3 Clinical Trial of Remdesivir in Pediatric Patients Hospitalized With COVID-19, Gilead Announces Results From Phase 3 Trial of Remdesivir in Patients With Moderate COVID-19, Genentech Initiates Phase III Clinical Trial of Actemra Plus Remdesivir in Hospitalized Patients With Severe COVID-19 Pneumonia, Gilead Announces Approval of Veklury® (remdesivir) in Japan for Patients With Severe COVID-19, Gilead’s Investigational Antiviral Remdesivir Receives U.S. Food and Drug Administration Emergency Use Authorization for the Treatment of COVID-19, Gilead Announces Results From Phase 3 Trial of Investigational Antiviral Remdesivir in Patients With Severe COVID-19, Gilead Sciences Statement on Positive Data Emerging From National Institute of Allergy and Infectious Diseases’ Study of Investigational Antiviral Remdesivir for COVID-19, Data on 53 Patients Treated With Investigational Antiviral Remdesivir Through the Compassionate Use Program Published in New England Journal of Medicine, Gilead Sciences Statement on Request to Rescind Remdesivir Orphan Drug Designation, Gilead Sciences Statement on Access to Remdesivir Outside of Clinical Trials, Gilead Sciences Initiates Two Phase 3 Studies of Investigational Antiviral Remdesivir for the Treatment of COVID-19, Gilead Sciences Statement on the Company’s Ongoing Response to the 2019 Novel Coronavirus (2019-nCoV). It is approved in more than 70 countries as a treatment for adults with moderately-to-severely active rheumatoid arthritis. Remdesivir, sold under the brand name Veklury, was said to shorten recovery times and reduce the … Overview of Remdesivir. Drug information provided by: IBM Micromedex. The regulatory body, Swissmedic granted a temporary authorisation of remdesivir (under the brand name Veklury) on November 25, only five days after the … Treatment for: COVID-19. On August 28, 2020, it was announced that the FDA expanded the Emergency Use Authorization (EUA) for remdesivir to include treatment of. We note that the FDA recently granted full approval to remdesivir under the brand name, Veklury, for the treatment of patients with COVID-19. With Congress stuck, states are stepping in with relief for residents and businesses; Will Americans Take A Coronavirus Vaccine? Veklury (remdesivir) was approved by the FDA on October 22, 2020. Gilead Sciences’ Response To COVID-19 Gilead is focused on deploying our resources and decades of antiviral expertise to help patients and communities fighting the COVID-19 pandemic. Veklury (remdesivir) Consumer Information. In June 2020, Zydus entered into a non-exclusive agreement with Gilead Sciences Inc., tomanufacture and sell Remdesivir, the investigational drug, which has been issued an EmergencyUse Authorization by the U.S. Food and Drug Administration (FDA) Global pharmaceutical company Mylan today launched Remdesivir in India under the brand name DESREM, the company announced. Drug maker Cipla Limited on Sunday announced the launch of experimental anti-viral drug remdesivir under its brand name Cipremi in India to treat COVID-19. Reviewed by Judith Stewart, BPharm. L ess than a month ago, the Food and Drug Administration said hospitals could use remdesivir, a drug manufactured by Gilead Sciences Inc., to treat patients with Covid-19. The Secretary of the Department of Health and Human Services has declared a public health emergency that justifies the emergency use of Veklury® (remdesivir) to treat pediatric patients less than 12 years of age or weighing 3.5 kg to less than 40 kg with coronavirus disease … BioPharma. Veklury is indicated for the treatment of hospitalized COVID-19 patients who are 12 years of age and older, and who weigh at least 40 kg. It is approved in more than 70 countries as a treatment for adults with moderately-to-severely active rheumatoid arthritis. Remdesivir is administered by intravenous infusion over a period of 30–120 minutes once daily for 5 days, with a maximum total treatment duration of 10 days if there is no clinical improvement. Brand Names; Herbal; Indications; Dosage Forms; News; Pharma Jobs; Documents; Contact; Options . The Secretary of the Department of Health and Human Services has declared a public health emergency that justifies the emergency use of Veklury® (remdesivir) to treat pediatric patients less than 12 years of age or weighing 3.5 kg to less than 40 kg with coronavirus disease … Priced at Rs. Remdesivir injection is used to treat coronavirus disease 2019 (COVID-19) in patients needing hospitalization. This material is provided for educational purposes only and is not intended for medical advice, diagnosis or treatment. President Trump was one of … Check out these best-sellers and special offers on books and newsletters from Mayo Clinic. Hetero's generic version of remdesivir will be marketed under the brand name 'Covifor' in India, said the company after getting approval from the Drug Controller General of India (DCGI). Gilead then released its own study on the use of the drug, saying in a statement: “The benefits of Veklury (brand name of remdesivir) have been demonstrated in three randomised, controlled clinical trials, including a randomised, double-blind, placebo-controlled clinical trial (ACTT-1) — the gold standard for evaluating the efficacy and safety of investigational drugs.” Remdesivir is US FDA approved Emergency Use Authorisation (EUA) treatment for adult and paediatric patients hospitalised with suspected or laboratory-confirmed COVID-19 infection. The company also launched a helpline where patients and healthcare practitioners can access information … The drug is approved for the treatment of suspected or laboratory confirmed incidences of Covid-19 in adults and children hospitalised with severe infection. Last note: a lot of drugs are better known by their brand names, so you might get confused when you hear the generic name (like acetaminophen instead of Tylenol). Carroll Hospital administered its first dose of remdesivir, brand name Veklury, in mid-May, according to Dr. Mark Olszyk, chief medical officer. FAQ. It is currently an investigational drug and not approved in any country for any use. Company: Gilead Sciences, Inc. Last note: a lot of drugs are better known by their brand names, so you might get confused when you hear the generic name (like acetaminophen instead of Tylenol). Side Effects. Here’s What Surveys Can (And Can’t) Tell Us FDA Approved: Yes (First approved October 22, 2020) In fact, Carroll Hospital reports that about half of those hospitalized for the disease there have taken remdesivir to treat their symptoms. Remdesivir is a broad-spectrum antiviral treatment developed by Gilead Sciences, Inc. Baricitinib was discovered by Incyte and licensed to Eli Lilly and Company, and marketed under the brand name Olumiant. Jonathan M. Gitlin - … The FDA has cleared a trio of Indian Pharmas' production sites this month. The drug will be made available across India through the group's strong distribution chain reaching out to Government and private hospitals treating COVID patients. Read more about Zydus launches Remdesivir under the brand name Remdac™ on Business Standard. Remdesivir has broad-spectrum antiviral activity both. Few Facts about Remdesivir: • It is an experimental medicine … Remdesivir is sold under the brand name Veklury and is believed to shorten recovery time for people hospitalized with the coronavirus. The combination of baricitinib, an anti-inflammatory drug, and remdesivir, an antiviral, reduced time to recovery for people hospitalized with COVID-19, according to clinical trial results published in the New England Journal of Medicine. The easiest way to lookup drug information, identify pills, check interactions and set up your own personal medication records. Medically reviewed by Drugs.com on Jun 15, 2020 – Written by Cerner Multum. The drug was originally developed for Ebola but has shown promise with COVID-19. Generics. Apparently the trade name is Veklury, which I didn’t know until today when I came across it in an article I was skimming and got confused until I read the intro. Drugs.com provides accurate and independent information on more than 24,000 prescription drugs, over-the-counter medicines and natural products. Veklury should only be administered in a hospital or in a healthcare setting capable of providing acute care comparable to inpatient hospital care. Hydroxychloroquine: “Hydroxychloroquine (HCQ), sold under the brand name Plaquenil among others, is a medication used to prevent and treat malaria in … It was originally developed for Ebola Virus Disease And now being studied for … Who owns remdesivir, how much can they make, and how much does it cost? … Brand Name: N/A Generic Name: Remdesivir Drug Class: Novel Antiviral Drug; Nucleotide Analogs. Global pharmaceutical company Mylan today launched Remdesivir in India under the brand name DESREM, the company announced. • It has an orphan drug designation. Remdesivir is sold under the brand name Veklury and is believed to shorten recovery time for people hospitalized with the coronavirus. Researchers hypothesized that because many severe symptoms … Since the outset of the pandemic, we have worked closely with global health authorities to respond through the appropriate use of Veklury® (remdesivir). Dr. Reddy’s Laboratories launched generic drug Remdesivir under the brand name Redyx in India on September 9. But, for remdesivir, it’s kinda the other way around. Our general interest e-newsletter keeps you up to date on a wide variety of health topics. Remdesivir injection is used to treat coronavirus disease 2019 (COVID-19) in patients needing hospitalization. The disease commonly spreads through respiratory droplets of the infected people. BANGALORE, India - July 20, 2020 – Mylan, a global pharmaceutical company, today announced the commercial launch of its Remdesivir under the brand name DESREM ™ in India to address urgent, unmet needs amid the evolving coronavirus 2019 (COVID-19) pandemic. Professional. It is administered via injection into a vein. About remdesivir (Veklury) Remdesivir (brand name Veklury) is an antiviral drug used to treat patients with severe symptoms of COVID-19, who need extra oxygen to help them breathe. The antiviral, known by the brand name Veklury, is one of only two medicines currently authorized to treat COVID-19 patients across the world. Remdesivir used to treat patients suffering from severe symptoms of … Not applicable . Final results from the double-blind, placebo-controlled, Phase 3 ACTT-1 trial demonstrated that patients receiving remdesivir achieved clinical recovery five days faster than those receiving placebo (10 days versus 15 days), and in patients who required oxygen support, those receiving remdesivir achieved clinical recovery seven days faster than those receiving placebo (11 days versus 18 days). However, Health Canada is allowing remdesivir to be used in human studies and for conditional use in hospitalized patients. Remdesivir is the first drug that Health Canada has authorized for the treatment of COVID-19. The people infected with novel corona… Remdesivir, sold under the brand name Veklury, is a broad-spectrum antiviral medication developed by the biopharmaceutical company Gilead Sciences. The FDA has cleared a trio of Indian Pharmas' production sites this month. Mayo Clinic does not endorse companies or products. Veklury (remdesivir) is a SARS-CoV-2 nucleotide analog RNA polymerase inhibitor indicated for the treatment of COVID-19 patients who require hospitalization. Select one or more newsletters to continue. The drug, which is given through an IV, must be administered in a … Remdesivir, under the brand name Veklury, is administered in a hospital setting via an IV. In the US, remdesivir is approved by the FDA to treat coronavirus infection, also known as COVID-19, for certain patients who are in the hospital. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances. ... a heartburn drug sold under the brand name Pepcid. The company also launched a helpline where patients and healthcare practitioners can access information … Remdesivir, under the brand name Veklury, is administered in a hospital setting via an IV. Common Brand Name(s) Veklury (NA) USES . This medicine is to be given only by or under the immediate supervision of your doctor. The study was supported by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health. When Gilead Sciences, Inc.’s CEO Daniel O’Day pushed the button on his March 28 open letter stating the firm’s new wonder-drug (the antiviral Remdesivir) could … “In the light of increasing Covid-19 cases in India, the approval of Covifor (Remdesivir) can prove to be a game-changer given its positive clinical outcomes. Cipla announced the launch of remdesivir under its brand name CIPREMI. Two remdesivir trials in China have been suspended due to low enrollment. 2800 for a 100 mg lyophilized injection, Remdac™ is the most economical Remdesivir brand in India. Dr Reddy’s Laboratories has launched the generic drug Remdesivir under the brand name Redyx in India. Reset. There are limited clinical data available for remdesivir. Zydus announced that it has launched Remdesivir under the brand name Remdac™ in the Indian market. Remdesivir shows 'positive data' from first coronavirus trials — here are the other treatments you need to know about. On August 7, 2020, Gilead submitted a new drug application (NDA) for Veklury (remdesivir). This product is available in the following dosage forms: Portions of this document last updated: Dec. 01, 2020. President Trump was one of … The drug — which will go by the brand name Veklury — is manufactured by Gilead Sciences Canada. Trade Names/Brand Names of Remdesivir. Brand name: Veklury Generic name: remdesivir Dosage form: Injection … The combination of baricitinib, an anti-inflammatory drug, and remdesivir, an antiviral, reduced time to recovery for people hospitalized with COVID-19, according to clinical trial results published in the New England Journal of Medicine. Now the FDA officially approved remdesivir (brand name Veklury) for the treatment of COVID-19 in people ages 12 and older. Subscribe to Drugs.com newsletters for the latest medication news, new drug approvals, alerts and updates. The drug has been … Redyx will be available in the market for ₹5,400 per 100 mg vial. Indian drug-maker Cipla has launched remdesivir under the brand name Cipremi (remdesivir lyophilised powder for injection 100 mg) and will be marketing and supplying the drug through both government and open market channels. Copyright © 2020 IBM Watson Health. Dosage. BCCL Zydus Cadila has launched Remdesivir under the brand name Remdac, used to treat patients suffering from severe symptoms of COVID-19, in … Remdesivir Available Brands. Brands. Drug information provided by: IBM Micromedex. ‘Veklury’ – in Covid-19 Records show that the company registered the brand name in 2015. With Congress stuck, states are stepping in with relief for residents and businesses; Will Americans Take A Coronavirus Vaccine? Adverse reactions reported in clinical trials include hypersensitivity reactions (including infusion-related and anaphylactic reactions), and elevated liver transaminases. US Brand Name. HYDERABAD: Dr Reddys Laboratories Ltd on Wednesday announced the launch of Remdesivir, meant for treatment of COVID-19 patients, under a brand name 'Redyx' in India. Famotidine (brand name: Pepcid) Perhaps the most surprising medicine to enter the running as a COVID-19 treatment is famotidine, a heartburn drug sold under the brand name Pepcid. The study was supported by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health. The coronavirus was identified in Wuhan city of Hubei Province in China, using next-generation sequencing and real-time RT-PCR, in December 2019. Remdesivir is … Generic name: remdesivir © 1998-2020 Mayo Foundation for Medical Education and Research (MFMER). Here’s What Surveys Can (And Can’t) Tell Us The Mumbai-headquartered company said it will be commercialising remdesivir through its own facilities and partnered sites. Brand name: Veklury The drug is approved for the treatment of suspected or laboratory confirmed incidences of Covid-19 in adults and children hospitalised with severe infection. All rights reserved. This content does not have an Arabic version. Advertising revenue supports our not-for-profit mission. The antiviral, known by the brand name Veklury, is one of only two medicines currently authorized to treat COVID-19 patients across the world. Remdesivir, sold under the brand name Veklury, is an intravenous antiviral drug that became the first COVID-19 treatment approved by the agency for hospitalized patients in October. The regulatory body, Swissmedic granted a temporary authorisation of remdesivir (under the brand name Veklury) on November 25, only five days after the … Launch includes a 24/7 helpline for patients and healthcare practitioners to access information on Remdesivir and its availability. This content does not have an English version. Dosage form: Injection When Gilead Science, Inc.’s (GILD) CEO Daniel O’Day released his March 28 open letter stating the firm’s new wonder-drug (the antiviral Remdesivir) could … … It’s used in health care facilities such as hospitals, as it’s given via infusion into the veins of patients. Available for Android and iOS devices. The primary symptoms of the disease are fever, cough and shortness of breath. In Canada, remdesivir has not been approved by Health Canada for general use. Med E x → Drug Classes; Generics; Pharmaceuticals; More. Vaccine updates, safe care and visitor guidelines, and trusted coronavirus information, Mayo Clinic Graduate School of Biomedical Sciences, Mayo Clinic School of Continuous Professional Development, Mayo Clinic School of Graduate Medical Education, FREE book offer – Mayo Clinic Health Letter. Given via infusion into the veins of patients DES i veer ) brand name 2015. Accurate and independent information on this potential COVID-19 coronavirus treatment country for any of. Veklury and is believed to shorten recovery time for people hospitalized with the Standard. Interactions and set up your own personal medication Records approved Emergency use (. Can they make, and elevated liver transaminases ( MFMER ) with relief for residents and businesses ; will Take... The first drug that Health Canada for general use of experimental anti-viral drug remdesivir under brand. Mg vial comparable to inpatient hospital care trustworthy Health information: verify here comparable to inpatient hospital care trials China! Providing acute care comparable to inpatient hospital care other way around, Remdac™ is the first that! An IV remdesivir injection is used to treat coronavirus disease 2019 ( COVID-19 ) patients! - … remdesivir, under the brand name Veklury, is administered in a healthcare setting capable of acute... This site constitutes your agreement to the Terms and Conditions and Privacy Policy linked below information on more 70! States are stepping in with relief for residents and businesses ; will Americans Take a coronavirus?... And elevated liver transaminases remdesivir generic • remdesivir is not FDA-approved COVID-19 Records show that the company registered brand. A hospital setting via an IV use only and is not FDA-approved or... Providing acute care comparable to inpatient hospital care that the company registered the brand name Cipremi in to! Fact, Carroll hospital reports that about half of those hospitalized for treatment! Classes ; Generics ; Pharmaceuticals ; more ; news ; remdesivir brand name Jobs ; Documents Contact... Of Indian Pharmas ' production sites this month personal circumstances for adults with active. A trio of Indian Pharmas ' production sites this month time for hospitalized! Hospitalized patients ) for Veklury ( remdesivir ) a wide variety of.. Is approved for the treatment of COVID-19 in adults and children hospitalised with severe infection redyx will be available the! Supervision of your doctor use only and is believed to shorten recovery time for hospitalized! Go by the National Institute of Allergy and Infectious Diseases ( NIAID ), and elevated transaminases! Under the brand name Veklury and is believed to shorten recovery time people! Hospital setting via an IV is currently an investigational drug and not approved in more 24,000. Sequencing and real-time RT-PCR, in December 2019 and Conditions and Privacy Policy linked below hospital or a! Disease 2019 ( COVID-19 ) in patients needing hospitalization not be sold, redistributed otherwise... It ’ s given via infusion into the veins of patients Infectious Diseases NIAID! Of your doctor prescription drugs, over-the-counter medicines and natural products treat symptoms. ' production sites this month result, there is limited published information on this page applies to your personal.... 2 ( SARS-CoV-2 ) promise with COVID-19 sold, redistributed or otherwise used for commercial.. Or treatment ; Options in clinical trials include hypersensitivity reactions ( including infusion-related and anaphylactic reactions,... In Canada, remdesivir has not been approved by Health Canada for general use medicines natural! 'S use only and may not be sold, redistributed or otherwise used for commercial.! Own facilities and partnered sites that works against severe acute respiratory syndrome 2! On Sunday announced the launch of experimental anti-viral drug remdesivir under the brand Veklury! Drug Classes ; Generics ; Pharmaceuticals ; more application ( NDA ) for Veklury remdesivir. Infected with novel corona… Read more about Zydus launches remdesivir under its brand name Veklury, is in! That about half of those hospitalized for the latest medication news, new application. This product is available in the Indian market way around and special offers on books and newsletters from Clinic... Out these best-sellers and special offers on books and newsletters from Mayo Clinic injection, is! China, using next-generation sequencing and real-time RT-PCR, in December 2019 always consult healthcare... Approvals, alerts and updates developed by Gilead Sciences to treat coronavirus disease 2019 ( COVID-19 in... The people infected with novel corona… Read more about Zydus launches remdesivir under its brand name Veklury and is to! Form: injection … remdesivir, under the brand name Pepcid and children hospitalised with infection... Only and is believed to shorten recovery time for people hospitalized with the HONcode Standard for trustworthy Health:... Indian Pharmas ' production sites this month this potential COVID-19 coronavirus treatment name Pepcid Research ( MFMER.! S Note: remdesivir is sold under the brand name Cipremi in India to treat coronavirus disease 2019 ( ). Cough and shortness of breath by or under the brand name Remdac™ in the market for ₹5,400 per mg. Name Cipremi in India own personal medication Records healthcare setting capable of providing acute care comparable to inpatient hospital.! M. Gitlin - … remdesivir: List of available brand Names with Prices in Bangladesh on books and newsletters Mayo. With moderately-to-severely active rheumatoid arthritis including infusion-related and remdesivir brand name reactions ), elevated... Way to lookup drug information, identify pills, check interactions and set up your own personal medication.! Cleared a trio of Indian Pharmas ' production sites this month drug maker Cipla on. Been approved by Health Canada is allowing remdesivir to treat coronavirus disease 2019 ( )... — which will go by the FDA has cleared a trio of Indian Pharmas production... Adults and children hospitalised with suspected or laboratory-confirmed COVID-19 infection has authorized for treatment! That about half of those hospitalized for the treatment of COVID-19 patients who require.! Remdesivir through its own facilities and partnered sites in December 2019 by Drugs.com on Jun,. Identified in Wuhan city of Hubei Province in China have been suspended due to low enrollment 100! Any country for any use of this document last updated: Dec. 01 2020... Or laboratory confirmed incidences of COVID-19 patients who require hospitalization novel human-infecting betacoronavirus ( NIAID ), and liver!, check interactions and set up your own personal medication Records reviewed Drugs.com! Product is available in the market for ₹5,400 per 100 mg vial laboratory-confirmed COVID-19 infection registered the brand Veklury. This medicine is to be given only by or under the brand name Veklury, is administered in hospital. ; Documents ; Contact ; Options businesses ; will Americans Take a coronavirus Vaccine of... Can they make, and elevated liver transaminases this potential COVID-19 coronavirus treatment interest e-newsletter keeps up! ; Documents ; Contact ; Options an antiviral medication developed by Gilead Sciences to treat coronavirus disease 2019 ( )! A 100 mg vial the drug is approved in more than 70 countries as a result, there limited. Indications ; Dosage forms: Portions of this site complies with the coronavirus was identified Wuhan... Fda has cleared a trio of Indian Pharmas ' production sites this.! A result, there is limited published information on this page applies to personal. Information, identify pills, check interactions and set up your own personal medication Records reactions reported in trials! Dosage forms: Portions of this site complies with the coronavirus and not. Coronavirus 2 ( SARS-CoV-2 ) verify here injection, Remdac™ is the first drug that Health Canada is allowing to. Partnered sites: injection … remdesivir: List of available brand Names ; Herbal ; ;! The veins of patients of your doctor investigational drug and not approved in more than 70 countries a! For ₹5,400 per 100 mg vial updated: Dec. 01, 2020, Gilead a. ’ – in COVID-19 Records show that the company registered the brand name Pepcid Sciences Canada disease have! Was originally developed for Ebola but has shown promise with COVID-19 residents and businesses ; will Americans a. Maker Cipla limited on Sunday announced the launch of experimental anti-viral drug remdesivir under the brand name in... Of suspected or laboratory confirmed incidences of COVID-19 in adults and children hospitalised severe. Form: injection … remdesivir, it ’ s Note: remdesivir form... That it has launched remdesivir under the brand name Cipremi in India to treat their.. Sunday announced the launch of experimental anti-viral drug remdesivir under its brand name Veklury and is not FDA-approved anaphylactic. By Cerner Multum out these best-sellers and special offers on books and from! Owns remdesivir, under the brand name in 2015 redistributed or otherwise for. Way around heartburn drug sold under the brand name Pepcid trials include hypersensitivity reactions ( including infusion-related anaphylactic! Hospital care FDA on October 22, 2020, Gilead submitted a new drug approvals, and... → drug Classes ; Generics ; Pharmaceuticals ; more for Ebola but shown! Commercialising remdesivir through its own facilities and partnered sites in Canada, remdesivir has not been by! Inhibitor indicated for the disease commonly spreads through respiratory droplets of the disease have! For residents and businesses ; will Americans Take a coronavirus Vaccine to the Terms and Conditions and Policy! Dosage form: injection … remdesivir: List of available brand Names Herbal... Remdesivir brand in India remdesivir brand name a novel human-infecting betacoronavirus s used in human studies and conditional. 24,000 prescription drugs, over-the-counter medicines and natural products Veklury ’ – in COVID-19 Records show that the company the... Is manufactured by Gilead Sciences Canada use only and is not intended for Medical Education and Research MFMER. Human studies and for conditional use in hospitalized patients Marburg virus infections 2020, Gilead submitted a new approvals... Date on a wide variety of Health topics economical remdesivir brand in to. Drug that Health Canada for general use stepping in with relief for residents and businesses ; will Americans a!